1 September 2024
Starpharma Boardroom Radio Interview
Melbourne, Australia; Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is pleased to provide investors with the opportunity to listen to an audio interview with Chief Executive Officer Dr Jackie Fairley on Boardroom Radio (BRR).
Dr Fairley is discussing the Company’s recent announcement of preliminary analyses of the pharmacokinetics (PK) of DEP™ docetaxel from the ongoing Phase 1 human clinical trial and the imminent launch of the VivaGel® condom in Australia.
The interview also refers to the status of other development programs at Starpharma, including VivaGel® for bacterial vaginosis.
To listen access via the below link, or copy the link into your web browser: